Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Efficacy and Safety Study of PTC124 as an Oral Treatment for Nonsense-Mutation-Mediated Cystic Fibrosis

NCT00803205 is registered in ClinicalTrials.gov with PTC Therapeutics as lead sponsor.

NCT NCT00803205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00803205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Efficacy and Safety Study of PTC124 as an Oral Treatment for Nonsense-Mutation-Mediated Cystic Fibrosis
Lead sponsor
PTC Therapeutics
Phase
Phase 3
Overall status
Completed
Start date
September 8, 2009
Completion date
November 12, 2011
Enrollment
238 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis